Cell-bound complement activation products associate with lupus severity in SLE.
Cristina ArriensRoberta Vezza AlexanderSonali NarainAmit SaxenaChristopher E CollinsDaniel J WallaceElena MassarottiJohn ConklinKenneth C KalunianChaim PuttermanRosalind Ramsey-GoldmanJill P BuyonAnca AskanaseRichard A FurieJudith A JamesGhalib A BelloSusan ManziJoseph AhearnTyler O'MalleyArthur WeinsteinThierry DervieuxPublished in: Lupus science & medicine (2021)
Abnormalities in complement activation as measured by CB-CAPs are associated with increased LSI.